Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 0.50 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
0.40 0.55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 3.19 -1.51 3
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 0.50 GBX

Motif Bio (MTFB) Latest News

More Motif Bio News
Motif Bio Investors    Motif Bio Takeover Rumours

Motif Bio (MTFB) Discussions and Chat

Motif Bio (MTFB) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Motif Bio trades in real-time

Motif Bio (MTFB) Top Chat Posts

DateSubject
25/11/2020
08:20
Motif Bio Daily Update: Motif Bio Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker MTFB. The last closing price for Motif Bio was 0.50p.
Motif Bio Plc has a 4 week average price of 0p and a 12 week average price of 0p.
The 1 year high share price is 1.75p while the 1 year low share price is currently 0.04p.
There are currently 654,991,023 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Motif Bio Plc is £3,274,955.12.
25/11/2020
20:22
scottdavid70: You remember this timeless classic comedy one liner from Graham about the EU submissions? You know the EMA that got quietly dropped without any...schhh don’t say anything...announcement. The type of management skill that says if we drop the HABP trials and EMA no one will notice. Of course these significant moments meaner we didn’t know anything about the liver issues that prompted the CRL but I am still in line for a BONUS whilst wiping the share price off the face of the planet..this is Capitalism at its finest and we should all be very quiet and accept these minor details as hard working ordinary shareholders
18/11/2020
06:14
scottdavid70: Arghhh the good old days with Peel Hunt at the slightly over optimistic level of pumping a stock. Good to have them back On board taking the companies cash after predictions like this one: Clinical stage bio company Motif Bio could see its share price surge early next year, argued Peel Hunt, with the US FDA due to give possible approval to Motif's antibiotic iclaprim on 13 February. Trading at 26p, Peel Hunt is targeting 95p. Fantasy stuff from the Peelers
13/11/2020
08:29
scottdavid70: To Motif would please remove the Board who have caused the share price to drop over 95% but are still involved and in the cusp of a BONUS?
13/11/2020
07:32
scottdavid70: Some more comedy gold from our Graham [...] All good news? Remember how the share price reacted to ‘all this good news?” What did they know then?
29/10/2020
09:46
scottdavid70: So why the need to ask shareholders to disapply the pre-emption rights? My honest opinion is that the Directors haven taken no risks with their own capital want in on the RTO. They want a slice of the pie that their shambolic handling of Iclaprim has presented, through sheer chance, because of Covid. A once in a generational occurrence we hope. They are now trying to figure out a way how to stuff their pockets with MORE free shares. They didn’t get the vote through so they are now trying to go done the fear mongering route by bringing Bobby back saying that it’s SIGNIFICANT DILUTION or delisting. However, if they were acting in the best interests of the company would that be the only two alternatives? No, I believe a simple RTO would suffice and as they didn’t purchase any shares with their own money (surprising when Lumsden was touting a share price of £1 when it was 30p, why wouldn’t he buy if he believed that? He is the greediest CEO I know) they want to reward themselves erroneously in my opinion with free shares and are working out how to sell the current shareholders the whole need for SIGNIFICANT DILUTION to allow them to do that. They could also do the RTO and buy in afterwards but that would expose them to risk like we have had to endure and they don’t seem particularly keen to do that do they?
27/10/2020
10:51
scottdavid70: If any of you are in any doubt would a company who has seen its share price decimated and say it’s installing strict cost controls then spend $332.000 on Director’s salaries etc as we say in the Interims? Simply answer is No. They themselves could have deferred salary payments till they got a deal done. They haven’t done one thing that has benefited the shareholders in 18 months. We have lost access to our money but they keep filling up their bank accounts.
23/10/2020
09:13
scottdavid70: Good for you Chuffer - let’s never let the Board and Lumsden forget what they said, what they have heralded and what they have tried to do whilst trying to steamroller shareholders rights whilst they have been the ones for responsible for the catastrophic share price decimation. Times are changing. Look at what Marcus Rashford is achieving and here we will also through the publication of what has unfolded here from the beginning many years ago..the CEO getting more incentives in salary for fundraising than actually for getting Iclaprim approved for example, to change the way shareholders are dealt with. It will take a lot of effort on my part and money, thankfully I have enough to see it through, to expose what shareholders have endured here.
20/9/2020
16:29
scottdavid70: 1) charge satisfied at companies house no RNS = no value for shareholders of Motif otherwise a RNS must be issued if it is to have a material impact on the Share Price 2) Patent issued no RNS = no value for shareholders of Motif otherwise a RNS must be issued if it is to have a material impact on the Share Price Pretty simple really - call Walbrook Monday and they will explain. No last minute news before the AGM to save Lumsden. The vote is happening and they have currently achieved zero for shareholders these past 18 months as far as we have been told officially.
13/7/2020
09:22
elsol: Zen - to correct you to avoid others getting mislead the charge/guarantee notification from Company's House on Friday (Not HMRC) is the January switch across/loan restructuring (January) of the MTFB PLC topco. guarantee/charge. In exchange Hercules the $7m debt holder took warrants (payment in kind of MTFB share options) in order to register a new charge onto the IP assets themselves that were owned and operated by MTFB Inc. So $7m did not change hands on Friday or just prior and its a bit of smoke and mirrors situation. We are back where we were on Thursday pre-the mistaken interpretation of the situation by some on these BBs (hence spike in share price Friday that is now correcting today). I hope this makes sense.
16/5/2020
12:17
moneymunch: Fair enough Lionheart, not many shares go up in a straight line but MTFB certainly has had a couple of goes, and so consequently you're always going to get profit takers to bring the share price down, and also a determined effort by the sharebashers, mostly on Lse who have been relentless to deter and discourage. They're either betting short or more likely working to get the price down for the very large buys that we've seen. Lombard's holds 16.85% and the 12.5m buy after close on Friday suggests another TR1 in the pipeline. I'm personally expecting a big bounce next week and if the share bashers are quiet, then we'll know their job is done, a TR1 will drop and the share price will.advance in anticipation of RTO news, which obviously gets closer every day. Gl :-)
Motif Bio share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201125 20:28:49